Open: 12:30 PM
Mesoblast Stock Price Graph
Mesoblast Stock Price Today
Mesoblast Limited (MESO) stock declined over -6.42% intraday to trade at $1.02 a share on NASDAQ. The stock opened with a gain of 5.45% at $1.16 and touched an intraday high of $1.21, falling -7.27% against the last close of $1.10. The Mesoblast Limited in stock market went to a low of $1.13 during the session.
Mesoblast Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Mesoblast Stock Price History Chart
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company's products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection; Rexlemestrocel-L to treat advanced chronic heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV for the treatment of biologic refractory rheumatoid arthritis diabetic nephropathy. The company has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. for the treatment of wound healing in patients with epidermolysis bullosa; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.
Frequently Asked Questions
What is the current Mesoblast Limited (MESO) stock price?
Mesoblast Limited (NASDAQ: MESO) stock price is $1.02 in the last trading session. During the trading session, MESO stock reached the peak price of $1.21 while $1.13 was the lowest point it dropped to. The percentage change in MESO stock occurred in the recent session was -6.42% while the dollar amount for the price change in MESO stock was -$0.07.
MESO's industry and sector of operation?
The NASDAQ listed MESO is part of Biotechnology industry that operates in the broader Healthcare sector. Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases.
Who are the executives of MESO?
Mr. Peter T. Howard B.Sc., L.L.B., BSc, LLB (Hons)
Gen. Counsel & Corporation Executive
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
Founder, Chief Executive Officer, MD, Chairman of Scientific Advisory Board & Executive Director
Dr. Philip R. Krause M.B.A., M.D., M.S.
Strategic Advisor & Director
Dr. Philip R. Krause M.B.A., M.D., M.S.
Strategic Advisor & Non Exec. Director
How MESO did perform over past 52-week?
MESO's closing price is 0.55% higher than its 52-week low of $1.13 where as its distance from 52-week high of $5.12 is -0.24%.
How many employees does MESO have?
Number of MESO employees currently stands at N/A. MESO operates from 55 Collins Street, Melbourne, VIC 3000, AU.
Link for MESO official website?
Official Website of MESO is: https://www.mesoblast.com
How do I contact MESO?
How many shares of MESO are traded daily?
MESO stock volume for the day was 409186.00 shares. The average number of MESO shares traded daily for last 3 months was 139.61 Thousands.
What is the market cap of MESO currently?
The market value of MESO currently stands at $207.51 Million with its latest stock price at $1.02 and N/A of its shares outstanding.